Home > Biodata Programs






Tuesday, March 1

  • 8:30 – 9:35

    Opening Plenary Session
    Welcome Introduction and Official Opening address

  • 8:45 – 9:35

    A panorama of the state of venture financing in France.

  • 9:35–11:35

    Company Presentations

  • 11:35-12:35

    One on One meeting sessions

  • 12:35–13:35

    Lunch

  • 13:30-14:30

    One on One meeting sessions

  • 14:30-16:30

    Company Presentations

  • 16:30-18:30

    Growing markets in specialty pharma.

  • 18:30

    cocktail

Tuesday, February 2nd

  • 9:00 – 10:05

    Opening Plenary Session

  • 9:00 – 9:15

    Welcome Introduction and Official Opening Address

  • 9:15–10:05

    Interactive session
    “Alzheimer’s Disease after the demise of the amyloid concept”

  • 10:05–10:35

    Coffee Break

  • 10:35–12:15

    Company Presentations

  • 12:15–13: 40

    Lunch

  • 13:40–15:45

    Company Presentations

  • 15:45–16:15

    Coffee Break

  • 16:15–17:05

    “Healthios, a long term view on investment banking”

Wednesday, March 2

  • 8:30 – 8:50

    Key Note:

  • 8:50 - 9:30

    Financing MedTech on the verge of commercialization

  • 9:35–11:35

    Company Presentations

  • 11:35-12:35

    One on One meeting sessions

  • 12:35–13:35

    Lunch

  • 13:30-14:30

    One on One meeting sessions

  • 14:30-16:30

    Company Presentations

  • 16:50 17:40

    REZONANCE
    Tech transfert in the financial crisis, a
    professional point of view

  • 17:40

    Networking cocktail

Wednesday, February 3rd

  • 9:00 - 9:40

    Interactive session

  • 9:40 – 8:55

    Oncology, what is new for solid tumors?”

  • 9:25 - 10:35

    Analyst Panel Discussion
    “Which stocks to watch in 2008 and beyond?”

  • 10:35 - 10:50

    Coffee Break

  • 10:50 - 12:30

    Company Presentations

  • 12:30 – 14:00

    Lunch

  • 14:00 – 15:40

    Company Presentations

  • 15:40 - 16:00

    Coffee Break

  • 16:00 – 18:00

    FIRST TUESDAY

  • 16:00 – 16:50

    Interactive Session
    Technopole d’Archamps, how to benefit from French
    and Swiss proximity

  • 16:50 – 17:40

    Interactive Session

  • 16:00 – 18:00

    “Medtech companies:European development and
    first market access, ois this sufficient